A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (mopp) vs. nitrogen mustard in advanced hodgkin's disease
โ Scribed by Charles M. Huguley Jr; John R. Durant; Russell R. Moores; Yick-Kwong Chan; Ronald F. Dorfman; Lorraine Johnson
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- English
- Weight
- 1016 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A patient with Hodgkin's disease (Stage IIB) was given nitrogen mustard shortly after diagnosis and has survived, without recurrence, for more than 5 years. HFhfOTHERAPY FOR CANCER IS OFTEN OF C palliative benefit but is only rarely curative. Single-agent chemotherapy4, 5 , 9 has achieved cure rate
Since the introduction of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, children with Hodgkin's disease (HD) have been treated with chemotherapy alone. The occurrence of side effects related to irradiation (especially secondary solid tumors) is less likely to occur.